The fungus can be somewhat hard to identify, which may lead to misidentification and wrong treatment.
And the pathogen’s outbreaks in hospital settings mean special precautions need to be taken to prevent its spread – much like the coronavirus.
Infections can be fatal, with the CDC estimating between 30 and 60 patients who contracted the fungus have died.
However, the available data is limited and many of the patients already had serious underlying conditions.
The CDC said: “Most C. auris infections are treatable with a class of antifungal drugs called echinocandins.
“However, some C. auris infections have been resistant to all three main classes of antifungal medications, making them more difficult to treat.”